Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

RSV Pneumonia Mortality: Hematological Malignancies As a Silent Amplifier - Insights from the National Inpatient Sample 2020

Zubair Hassan Bodla, Mariam Hashmi, Fatima Niaz, Austin Auyeung, Muhammad Junaid Tariq, Muhammad Jahanzeb Khalil, Farhan Khalid, Christopher Bray

Blood (2023) 142 (Supplement 1): 4203.

https://doi.org/10.1182/blood-2023-185046

Published: 2023

Journal Articles

Efficacy of High Dose Chemotherapy with Autologous Transplantation for Primary CNS Lymphoma Treatment

Muhammad Khawar Sana, MD, Syed Maaz Abdullah, MBBS, Muhammad Tayyeb, MD, Mohammad Ammad Ud Din, MD, Amrat Ehsan, MD, Abdul Jabbar Dar, MD, Qasim Khurshid, MD, Sikander Abdullah, MBBS, Karun Neupane, MBBS,MD, Mobeen Zaka Haider, MDMBBS, Muhammad Jahanzeb Khalil, MD, Hamid Ehsan, MDMBBS, Syed Ziauddin A Zaidi, FRCP,FRCPath,MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-141450

Published: 2020

Journal Articles

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review

Muhammad Aadil Rahman, MD, Ali Younas Khan, MD, Awais Ijaz, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Asad Fraz, MD, Faiza Jamil, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Ahmad Safdar, BS, Ali McBride, PharmD,MS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 2025.

https://doi.org/10.1182/blood-2018-99-115214

Published: 2018

Journal Articles

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

Muhammad Junaid Tariq, MD, Muhammad Yasir, MD, Amna Khalid, MD, Saher Nasir Amin, MD, Sharoon Samuel, MBBS, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Asad Fraz, MD, Muhammad Usman, MD, Awais Ijaz, MD, Arafat Ali Farooqui, MBBS, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5231.

https://doi.org/10.1182/blood-2018-99-116819

Published: 2018

Journal Articles

Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors

Ali Younas Khan, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Awais Ijaz, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Hafiz Muhammad Fazeel, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Asad Fraz, MD, Muhammad Jahanzeb Khalil, MD, Jemin Aby Jose, MD, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5477.

https://doi.org/10.1182/blood-2018-99-115408

Published: 2018

Journal Articles

Efficacy of Lenalidomide Based Three Drug Versus Two Drug Regimen for Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials

Muhammad Usman, MD, Warda Faridi, MD, Muhammad Asad Fraz, MD, Muhammad Junaid Tariq, MD, Saad Ullah Malik, MD, Fnu Sagar, MD, Awais Ijaz, MD, Abid Hussain, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Amna Khalid, MD, Midhat Lakhani, MD, Ceren Durer, MD, Seren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 3239.

https://doi.org/10.1182/blood-2018-99-111930

Published: 2018

Journal Articles

Presentation Pattern, Diagnostic Markers, Management and Outcome of IgD Multiple Myeloma: A Systematic Review

Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Junaid Tariq, MD, Seren Durer, MD, Ceren Durer, MD, Madeeha Shafqat, Shehroz Aslam, MD, Zunairah Shah, MBBS, Anum Qureshi, Faiza Jamil, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Muhammad Masab, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 3309.

https://doi.org/10.1182/blood-2018-99-116959

Published: 2018

Journal Articles

Targeting Intracellular Signaling Cascades for Patients with Relapsed, Refractory Multiple Myeloma: A Systematic Review of Clinical Trials

Shehroz Aslam, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Rida Riaz, MBBS, Seren Durer, MD, Ceren Durer, MD, Faisal Mahfooz, MD, Muhammad Jahanzeb Khalil, MD, Jemin Aby Jose, MD, Zunairah Shah, MBBS, Chaudhry Saad Sohail, MD, Maaz Ahmed Yusufi, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5659.

https://doi.org/10.1182/blood-2018-99-115721

Published: 2018

Journal Articles

Histone Deacetylase Inhibitors in Myelodysplastic Syndrome

Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Muhammad Sardar, MD, Zunairah Shah, MBBS, Madeeha Shafqat, Warda Faridi, MD, Mustafa Nadeem Malik, MD, Muhammad Yasir, MD, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Anum Qureshi, Shamudeen Rafiyath, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5528.

https://doi.org/10.1182/blood-2018-99-119728

Published: 2018

Journal Articles

A Single Center Retrospective Evaluation of Daratumumab Infusion Related Reactions with Split-First Dose Day 1 and Day 2 Infusion

Ali McBride, PharmD,MS, Muhammad Usman, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Junaid Tariq, MD, Muhammad Asad Fraz, MD, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Ali Younas Khan, MD, Sharoon Samuel, MD, Insija Ilyas Selene, MBBS, James Camamo, Cara Chang, PharmD, Jemin Aby Jose, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5667.

https://doi.org/10.1182/blood-2018-99-119736

Published: 2018

Journal Articles

Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma - a Systematic Review of Early Phase Clinical Trials

Sharoon Samuel, MBBS, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Amna Khalid, MD, Muhammad Asad Fraz, MD, Awais Ijaz, MD, Faiza Jamil, MD, Muhammad Yasir, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Shehroz Aslam, MD, Madeeha Shafqat, Ceren Durer, MD, Zunairah Shah, MBBS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5629.

https://doi.org/10.1182/blood-2018-99-114019

Published: 2018

Journal Articles

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Sharoon Samuel, MBBS, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Jahanzeb Khalil, MD, Muhammad Yasir, MD, Saher Nasir Amin, MD, Ahmad Safdar, Abdul Rafae, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5635.

https://doi.org/10.1182/blood-2018-99-115922

Published: 2018

Journal Articles

The Use of Checkpoint Inhibitors before and after Allogeneic Stem Cell Transplantion: A Double-Edged Sword

Ali Younas Khan, MD, Awais Ijaz, MD, Muhammad Usman, MD, Muhammad Junaid Tariq, MD, Muhammad Asad Fraz, MD, Muhammad Jahanzeb Khalil, MD, Ceren Durer, MD, Seren Durer, MD, Fnu Sagar, MD, Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Zunairah Shah, MBBS, Shehroz Aslam, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5722.

https://doi.org/10.1182/blood-2018-99-110006

Published: 2018

Journal Articles

Diagnostic and Prognostic Role of Fecal Calprotectin As a Biomarker for Gastrointestinal Graft Versus Host Disease: A Systematic Review of Literature

Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Ali Younas Khan, MD, Anum Qureshi, Muhammad Abu Zar, MD, Ceren Durer, MD, Seren Durer, MD, Ahmad Kamal, MD, Insija Ilyas Selene, MBBS, Jemin Aby Jose, MD, Muhammad Jahanzeb Khalil, MD, Hafiz Muhammad Fazeel, MD, Muhammad Usman, MD, Awais Ijaz, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5725.

https://doi.org/10.1182/blood-2018-99-109857

Published: 2018

Journal Articles

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Muhammad Yasir, MD, Muhammad Junaid Tariq, MD, Arshia Akbar, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Muhammad Umair Jahngir, Ali Younas Khan, MD, Awais Ijaz, MD, Ceren Durer, MD, Seren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5559.

https://doi.org/10.1182/blood-2018-99-117084

Published: 2018

Journal Articles

Efficacy, Toxicity and Targets for Adoptive Cellular Therapy in Multiple Myeloma: A Systematic Review

Muhammad Usman, MD, Muhammad Junaid Tariq, MD, Awais Ijaz, MD, Muhammad Asad Fraz, MD, Ali Younas Khan, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Muhammad Jahanzeb Khalil, MD, Arveen Asghar, Seren Durer, MD, Ceren Durer, MD, Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Mustafa Nadeem Malik, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5649.

https://doi.org/10.1182/blood-2018-99-109944

Published: 2018

Journal Articles

Antibodies in Development for Multiple Myeloma: A Systematic Review

Muhammad Asad Fraz, MD, Muhammad Junaid Tariq, MD, Muhammad Usman, MD, Nadia Carenina Nunes Cavalcante Parr, MD, Awais Ijaz, MD, Malik Qistas Ahmad, MD MBBS, Muhammad Yasir, MD, Seren Durer, MD, Muhammad Jahanzeb Khalil, MD, Ceren Durer, MD, Sharoon Samuel, MBBS, Saher Nasir Amin, MD, Ahmad Safdar, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5656.

https://doi.org/10.1182/blood-2018-99-114224

Published: 2018

Journal Articles

Clinical Efficacy of Intracellular Molecular Inhibitors for Relapsed, Refractory Multiple Myeloma: A Systematic Review of Early Clinical Data

Shehroz Aslam, MD, Mustafa Nadeem Malik, MD, Abdul Rafae, MD, Rida Riaz, MBBS, Muhammad Jahanzeb Khalil, MD, Faisal Mahfooz, MD, Madeeha Shafqat, Anum Qureshi, Insija Ilyas Selene, MBBS, Syed Shabee Hassan, MD, Muhammad Junaid Tariq, MD, Muhammad Yasir, MD, Sharoon Samuel, MBBS, Maryam Sadiq, MBBS, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1950.

https://doi.org/10.1182/blood-2018-99-111587

Published: 2018

NARROW

RSV Pneumonia Mortality: Hematological Malignancies As a Silent Amplifier - Insights from the National Inpatient Sample 2020

Efficacy of High Dose Chemotherapy with Autologous Transplantation for Primary CNS Lymphoma Treatment

Efficacy and Tolerability of Daratumumab in Heavily Pretreated AL Amyloidosis: A Systematic Review

Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies - a Systematic Review

Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors

Efficacy of Lenalidomide Based Three Drug Versus Two Drug Regimen for Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Randomized Trials

Presentation Pattern, Diagnostic Markers, Management and Outcome of IgD Multiple Myeloma: A Systematic Review

Targeting Intracellular Signaling Cascades for Patients with Relapsed, Refractory Multiple Myeloma: A Systematic Review of Clinical Trials

Histone Deacetylase Inhibitors in Myelodysplastic Syndrome

A Single Center Retrospective Evaluation of Daratumumab Infusion Related Reactions with Split-First Dose Day 1 and Day 2 Infusion

Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma - a Systematic Review of Early Phase Clinical Trials

A Decade of Anti-Myeloma Vaccine Development through Early Phase Trials: A Systematic Review

The Use of Checkpoint Inhibitors before and after Allogeneic Stem Cell Transplantion: A Double-Edged Sword

Diagnostic and Prognostic Role of Fecal Calprotectin As a Biomarker for Gastrointestinal Graft Versus Host Disease: A Systematic Review of Literature

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Efficacy, Toxicity and Targets for Adoptive Cellular Therapy in Multiple Myeloma: A Systematic Review

Antibodies in Development for Multiple Myeloma: A Systematic Review

Clinical Efficacy of Intracellular Molecular Inhibitors for Relapsed, Refractory Multiple Myeloma: A Systematic Review of Early Clinical Data

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only